Transfer of Inhaled Cannabis Into Human Breastmilk

This article appears in the May 2018 Issue of Obstetrics & Gynecology. You can access the article by clicking HERE.

The objective of the study was to evaluate the transfer of delta-9-tetrahydrocannabinol and its metabolites into human breast milk after maternal inhalation of 0.1 g cannabis containing 23.18% delta-9-tetrahydrocannabinol. (In clear language – what’s the effect of smoking pot on your breast milk?)

This study documents inhaled delta-9-tetrahydrocannabinol transfer into the mother’s breast milk. Low concentrations of delta-9-tetrahydrocannabinol were detected. The long-term neurobehavioral effect of exposure to delta-9-tetrahydrocannabinol on the developing brain is unclear. Mothers should be cautious using cannabis during pregnancy and breastfeeding.

In short – if you smoke pot, this study indicates it will get into your breast milk.

Factors Influencing Repeated Teenage Pregnancy

Factors influencing repeated teenage pregnancy: a review and meta-analysis

Existing evidence of predictors of repeated teenage pregnancy has not been assessed rigorously. This systematic review provides a comprehensive evaluation of protective and risk factors that are associated with repeated teenage pregnancy through a metaanalytical consensus

Presented at the 15th World Congress on Public Health, Melbourne, Australia, April 3-7, 2017 by

Joemer C. Maravilla, RN, James C. Maravilla, RN, Kim S. Betts, PhD, Rosa Alati, Phd, and Camila Couto e Crus

You can access the article by clicking HERE.

First U.S. Birth From Uterine Transplant Recipient

Kari Oakes reports in Ob.Gyn.News that a woman with a transplanted uterus gave birth to a live baby boy in Dallas, the first birth from a transplanted uterus in the United States. It is also the first birth resulting from uterine transplantation to be performed outside of Sweden, where a total of eight births have occurred.

You can read the entire article by clicking HERE.

Menopause – Removing “Fear” From Hormone Therapy

Kari Oakes writes an interesting article published in the October 14, 2017 issue of OB.Gyn News that it is time to take the fear out of the hormone therapy conversation.

“I want to take fear out of the conversation. Hormone therapy remains the most effective treatment for vasomotor symptoms and the genitourinary syndrome of menopause and has been shown to prevent bone loss and fracture,” said Dr. JoAnn Pinkerton, who also chaired the advisory panel that penned the 2017 NAMS position statement on hormone therapy.

You can read the entire article by clicking HERE.

 

Syphilis Spike – Prenatal Care is Critical!

A spike in syphilis puts prenatal care in focus

Fifteen years ago, reported cases of syphilis in the United States were so infrequent that public health officials thought it might join the ranks of malaria, polio, and smallpox as an eradicated disease.

That turned out to be wishful thinking.

According to data from the Centers for Disease Control and Prevention, between 2012 and 2015, the overall rates of syphilis in the United States increased by 48%, while the rates of primary and secondary infection among women spiked by 56%. That was a compelling enough rise, but fresh data from the agency indicate that the overall rates of syphilis increased by 17.6% between 2015 and 2016, and by 74% between 2012 and 2016.

You can read the entire article by clicking HERE.

Trimester Zero: (Part 1) Pregnancy wellness begins before the positive pregnancy test.

This article, appearing in the March 2017 issue of Contemporary OB/GYN and written Yalda Afshar MD PhD and Christina S Han MD, cites preconception care as primary prevention.

The goal is to affirm pregnancy intention, reduce any potential harm, and recognize modifiable risk factors related to pregnancy while stratifying pregnancies on a continuum of low- to high-risk.

Read the entire article by clicking HERE.